Related Experiment Videos

[Long-term health-related quality of life in chronic hepatitis B patients]

Gui-cheng Wu1, Wei-ping Zhou, You-rong Zhao

  • 1Institute for Viral Hepatitis, Chongqing University of Medical Sciences, Chongqing 400010, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|May 30, 2003
PubMed

Insights

Long-term health-related quality of life (HQL) in chronic hepatitis B (CHB) patients is significantly poorer than in the general population. This study highlights the long-term impact of CHB on patient well-being.

Area of Science:

  • Hepatology
  • Public Health
  • Quality of Life Research

Context:

  • Chronic hepatitis B (CHB) is a significant global health concern.
  • Long-term outcomes and quality of life for CHB patients require further investigation.
  • Antiviral drug efficacy and economic impact are crucial considerations in CHB management.

Purpose:

  • To assess the long-term health-related quality of life (HQL) in patients with chronic hepatitis B (CHB).
  • To evaluate the efficacy and economic significance of antiviral drugs in managing CHB.
  • To compare the HQL of CHB patients with that of the general population.

Summary:

  • A study involving 101 CHB patients and 105 controls used the SF-36 questionnaire to assess HQL.
  • CHB patients reported significantly lower HQL in physical functioning, role physical, general health, and mental health domains.
  • Specific symptoms also showed a significant negative impact on the HQL of CHB patients.

Impact:

  • The findings indicate that long-term HQL in CHB patients is generally poor.
  • This research highlights the need for interventions to improve the quality of life for individuals living with CHB.
  • Understanding HQL deficits can inform healthcare strategies and the development of more effective treatments.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...